首页> 外文期刊>American Journal of Kidney Diseases: The official journal of the National Kidney Foundation >ICOSAPENT ETHYL REDUCES POTENTIALLY ATHEROGENIC LIPID AND INFLAMMATORY MARKERS IN HIGH-RISK STATIN-TREATED PATIENTS WITH PERSISTENT HIGH TRIGLYCERIDES, EGFR 90 ML/MIN/1.73 M2, AND ELEVATED HIGH-SENSITIVITY C-REACTIVE PROTEIN = 2.0 MG/L
【24h】

ICOSAPENT ETHYL REDUCES POTENTIALLY ATHEROGENIC LIPID AND INFLAMMATORY MARKERS IN HIGH-RISK STATIN-TREATED PATIENTS WITH PERSISTENT HIGH TRIGLYCERIDES, EGFR 90 ML/MIN/1.73 M2, AND ELEVATED HIGH-SENSITIVITY C-REACTIVE PROTEIN = 2.0 MG/L

机译:icOsapent乙基降低了高危血液治疗患者的潜在致动血液和炎症标志物,持续高甘油三酯,EGFR& 90 ml / min / 1.73m 2,高敏感性C-反应蛋白& = 2.0 mg / L.

获取原文
获取原文并翻译 | 示例
           

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号